Independent coordination for scientifically
robust and operationally aligned preclinical
studies across Europe.
Coordinating science, strategy, and compliance to accelerate
preclinical success across Europe.

Structured multi-site project execution

Expertise in Paragraph 44 and Article 9 licensing

Access to trusted European scientific partners

Consolidated data insights for investors and publications
InVivoBridge is an independent consulting and coordination partner supporting early-stage biotech companies developing vaccines, biologics, and anti-infective therapies.
We specialize in connecting science with strategy helping biotech teams design, plan, and coordinate preclinical in vivo studies through a trusted European network of academic and CRO partners.
Unlike contract research organizations (CROs), InVivoBridge does not perform laboratory experiments.
Instead, we bring scientific and operational alignment to every project ensuring that the right partners, models, and regulatory frameworks are in place before execution begins.
Our mission is to bridge communication gaps between scientists, partners, and regulators, accelerating decision-making and improving the quality of preclinical outcomes.
InVivoBridge simplifies one of the hardest parts of biotech innovation — coordinating complex in vivo programs across partners and regulatory systems with precision and structure.
Client and partner feedback reflects the clarity and structure that InVivoBridge brings to preclinical coordination. Our collaborators value scientific precision, communication, and independent oversight.
“Dr. Kanwal brings structure and clarity to complex preclinical programs.” — CRO Partner, Germany
“Independent, structured, and deeply scientific — exactly what translational projects need.” — Academic Collaborator, Netherlands
Let’s align science, strategy, and execution to accelerate your next in vivo program efficiently and compliantly across Europe.
Study Coordination
Regulatory Support
CRO + Academic Collaboration
Integrated Reporting
Immunology Model Access